- Home
- JBLU vs IDYA Comparison
JBLU vs IDYA Comparison
Compare JBLU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBLU
- IDYA
- Stock Information
- Founded
- JBLU 1998
- IDYA 2015
- Country
- JBLU United States
- IDYA United States
- Employees
- JBLU N/A
- IDYA N/A
- Industry
- JBLU Air Freight/Delivery Services
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- JBLU Consumer Discretionary
- IDYA Health Care
- Exchange
- JBLU Nasdaq
- IDYA Nasdaq
- Market Cap
- JBLU 2.1B
- IDYA 2.0B
- IPO Year
- JBLU N/A
- IDYA 2019
- Fundamental
- Price
- JBLU $5.75
- IDYA $18.51
- Analyst Decision
- JBLU Sell
- IDYA Strong Buy
- Analyst Count
- JBLU 12
- IDYA 13
- Target Price
- JBLU $6.15
- IDYA $53.58
- AVG Volume (30 Days)
- JBLU 22.3M
- IDYA 959.0K
- Earning Date
- JBLU 04-22-2025
- IDYA 05-06-2025
- Dividend Yield
- JBLU N/A
- IDYA N/A
- EPS Growth
- JBLU N/A
- IDYA N/A
- EPS
- JBLU N/A
- IDYA N/A
- Revenue
- JBLU $9,279,000,000.00
- IDYA $7,000,000.00
- Revenue This Year
- JBLU $7.02
- IDYA $89.14
- Revenue Next Year
- JBLU $6.21
- IDYA $291.34
- P/E Ratio
- JBLU N/A
- IDYA N/A
- Revenue Growth
- JBLU N/A
- IDYA N/A
- 52 Week Low
- JBLU $4.50
- IDYA $16.95
- 52 Week High
- JBLU $8.31
- IDYA $46.40
- Technical
- Relative Strength Index (RSI)
- JBLU 38.79
- IDYA 35.90
- Support Level
- JBLU $5.46
- IDYA $18.20
- Resistance Level
- JBLU $6.53
- IDYA $19.67
- Average True Range (ATR)
- JBLU 0.40
- IDYA 1.11
- MACD
- JBLU -0.09
- IDYA -0.15
- Stochastic Oscillator
- JBLU 13.90
- IDYA 28.52
About JBLU JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The operating segments of company are Domestic & Canada, Caribbean & Latin America and Atlantic. Majority of revenue is generated from Domestic & Canada segment.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.